MDMI-Just announced merger
The Company is pleased to announce that on December 2, 2003, it entered into an agreement to acquire an exclusive worldwide License from MDMI Technologies, Inc. ("MDMI"), of Richmond, British Columbia, to apply their proprietary "Thermal Ablation Technology" to augment the Company's URO-Stent in the treatment of Benign Prostate Hyperplasia (BPH). BPH is a non-cancerous enlargement of the prostate,